These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The catalytic subunit of phosphatidylinositol 3-kinase is a substrate for the activated platelet-derived growth factor receptor, but not for middle-T antigen-pp60c-src complexes. Roche S, Dhand R, Waterfield MD, Courtneidge SA. Biochem J; 1994 Aug 01; 301 ( Pt 3)(Pt 3):703-11. PubMed ID: 7519847 [Abstract] [Full Text] [Related]
4. Lovastatin inhibits platelet-derived growth factor (PDGF) stimulation of phosphatidylinositol 3-kinase activity as well as association of p85 subunit to tyrosine-phosphorylated PDGF receptor. McGuire TF, Corey SJ, Sebti SM. J Biol Chem; 1993 Oct 25; 268(30):22227-30. PubMed ID: 7693661 [Abstract] [Full Text] [Related]
5. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively. Valius M, Bazenet C, Kazlauskas A. Mol Cell Biol; 1993 Jan 25; 13(1):133-43. PubMed ID: 7678051 [Abstract] [Full Text] [Related]
6. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Nishimura R, Li W, Kashishian A, Mondino A, Zhou M, Cooper J, Schlessinger J. Mol Cell Biol; 1993 Nov 25; 13(11):6889-96. PubMed ID: 7692233 [Abstract] [Full Text] [Related]
20. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner. Zhang-Sun G, Yang C, Viallet J, Feng G, Bergeron JJ, Posner BI. Endocrinology; 1996 Jul 05; 137(7):2649-58. PubMed ID: 8770882 [Abstract] [Full Text] [Related] Page: [Next] [New Search]